Log in
Enquire now
Acies Bio

Acies Bio

Provides strain development, fermentation, chemistry, and other services.

OverviewStructured DataIssuesContributors

Contents

aciesbio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Health technology
Health technology
‌
Product Research
Agriculture
Agriculture
Pharmaceutical industry
Pharmaceutical industry
Biopharma
Biopharma
Technology
Technology
Biology
Biology
...
Location
Ljubljana
Ljubljana
0
B2X
B2B
B2B
CEO
Štefan Fujs
Štefan Fujs
Founder
Enej Kuscer
Enej Kuscer
0
Štefan Fujs
Štefan Fujs
0
‌
Gregor Kosec
0
Date Incorporated
2006
Spinout
TM3 Therapeutics
TM3 Therapeutics
Number of Employees (Ranges)
11 – 50
Email Address
Phone Number
Full Address
Tehnoloski park 21 1000, Ljubljana Slovenia0
Investors
EASME (EU Executive Agency for SMEs)
EASME (EU Executive Agency for SMEs)
Founded Date
January 1, 2006
Fax Number
+386 59 075 9940
Total Funding Amount (USD)
2,169,099
Latest Funding Round Date
November 2015
Latest Funding Type
‌
Grant (money)
Country
Slovenia
Slovenia
0
Headquarters
Ljubljana
Ljubljana

Other attributes

Company Operating Status
Active
Wikidata ID
Q30299295

ACIES BIO is a biotechnology contract research organization offering R&D services to pharmaceutical, chemical, biotech and food industries. The company provides full support from idea conceptualization through research to product development.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Acies Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.